MC
PACB icon

Maverick Capital’s Pacific Biosciences PACB Stock Holding History

Maverick Capital’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-12,173,094
Closed -$65.9M – 285
2018
Q3 		$65.9M Hold
12,173,094
– – 0.82% 29
2018
Q2 		$43.2M Hold
12,173,094
– – 0.51% 35
2018
Q1 		$25M Buy
12,173,094
+950,000
+8% +$2.47M 0.32% 40
2017
Q4 		$29.6M Buy
11,223,094
+619,150
+6% +$2.17M 0.37% 31
2017
Q3 		$55.7M Hold
10,603,944
– – 0.71% 31
2017
Q2 		$37.8M Buy
10,603,944
+1,530,070
+17% +$6.17M 0.47% 31
2017
Q1 		$46.9M Hold
9,073,874
– – 0.6% 30
2016
Q4 		$34.5M Sell
9,073,874
-21,789
-0.2% -$158K 0.45% 28
2016
Q3 		$81.5M Buy
9,095,663
+1,274,855
+16% +$10.7M 0.97% 26
2016
Q2 		$55M Buy
7,820,808
+259,540
+3% +$2.37M 0.75% 25
2016
Q1 		$64.3M Hold
7,561,268
– – 1.02% 29
2015
Q4 		$99.3M Buy
7,561,268
+105,234
+1% +$944K 1.43% 28
2015
Q3 		$27.3M Buy
7,456,034
+395,000
+6% +$1.93M 0.47% 31
2015
Q2 		$40.7M Hold
7,061,034
– – 0.62% 31
2015
Q1 		$41.2M Buy
7,061,034
+601,250
+9% +$4.15M 0.66% 35
2014
Q4 		$50.6M Hold
6,459,784
– – 0.79% 35
2014
Q3 		$31.7M Hold
6,459,784
– – 0.46% 40
2014
Q2 		$39.9M Hold
6,459,784
– – 0.57% 38
2014
Q1 		$34.6M Hold
6,459,784
– – 0.48% 39
2013
Q4 		$33.8M Buy
6,459,784
+645,065
+11% +$2.96M 0.44% 51
2013
Q3 		$32.1M Buy
5,814,719
+2,282,766
+65% +$7.92M 0.43% 52
2013
Q2 		$8.94M Buy
+3,531,953
New +$8.79M 0.12% 55

Other funds holding PACB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Maverick Capital's PACB Position: Q4 2018 in Review

Maverick Capital sold out of Pacific Biosciences (PACB) in Q4 2018, closing a stake of 12,173,094 shares — an estimated $65.9M sold.

Maverick Capital first reported a position in PACB in Q2 2013 and held it in 22 quarters. The position peaked at $99.3M in Q4 2015. 155 funds tracked by Wall St. Rank hold PACB as of Q4 2018.

  • Maverick Capital reported no remaining Pacific Biosciences position as of Q4 2018 after selling out during the quarter.
  • Maverick Capital sold 12,173,094 Pacific Biosciences shares in Q4 2018, an estimated $65.9M.
  • Maverick Capital first reported a position in Pacific Biosciences in Q2 2013 and held it in 22 quarters.
  • Maverick Capital's Pacific Biosciences position peaked at $99.3M in Q4 2015.
  • 155 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2018.

Based on Maverick Capital's 13F filing for Q4 2018, filed 14 Feb 2019.